This is a four-arm study of alternative preventive therapy regimens for latent TB in HIV-infected adults. The study will provide critically important information on the most effective therapies to prevent HIV-related TB, and will assess the potency of short-course regimens containing rifamycins, as well as life-long therapy with isoniazid. The study has enrolled >1000 patients to date, and will be completed in 2006.